Trilogy Capital Inc. grew its position in shares of Cardinal Health Inc (NYSE:CAH) by 237.1% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,512 shares of the company’s stock after purchasing an additional 10,911 shares during the period. Trilogy Capital Inc.’s holdings in Cardinal Health were worth $747,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. WP Advisors LLC acquired a new position in Cardinal Health during the first quarter worth $26,000. Gemmer Asset Management LLC raised its stake in shares of Cardinal Health by 172.4% in the fourth quarter. Gemmer Asset Management LLC now owns 553 shares of the company’s stock valued at $25,000 after acquiring an additional 350 shares in the last quarter. Transamerica Financial Advisors Inc. acquired a new stake in shares of Cardinal Health in the fourth quarter valued at $32,000. CNB Bank acquired a new stake in shares of Cardinal Health in the fourth quarter valued at $36,000. Finally, American Research & Management Co. acquired a new stake in shares of Cardinal Health in the first quarter valued at $48,000. Institutional investors own 87.83% of the company’s stock.
CAH has been the topic of several analyst reports. ValuEngine cut Cardinal Health from a “sell” rating to a “strong sell” rating in a research note on Tuesday, December 18th. Zacks Investment Research lowered Cardinal Health from a “hold” rating to a “sell” rating in a report on Wednesday, January 9th. UBS Group assumed coverage on Cardinal Health in a report on Thursday, January 17th. They issued a “neutral” rating and a $51.00 target price on the stock. Finally, Wolfe Research assumed coverage on Cardinal Health in a report on Tuesday, April 2nd. They issued an “underperform” rating on the stock. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the stock. Cardinal Health presently has an average rating of “Hold” and a consensus target price of $56.78.
NYSE:CAH opened at $46.75 on Wednesday. The firm has a market capitalization of $13.93 billion, a P/E ratio of 9.35, a price-to-earnings-growth ratio of 1.50 and a beta of 1.15. The company has a debt-to-equity ratio of 1.26, a quick ratio of 0.51 and a current ratio of 1.05. Cardinal Health Inc has a 12 month low of $42.17 and a 12 month high of $66.45.
Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, February 7th. The company reported $1.29 EPS for the quarter, beating the consensus estimate of $1.09 by $0.20. The firm had revenue of $37.70 billion for the quarter, compared to analyst estimates of $36.09 billion. Cardinal Health had a positive return on equity of 24.01% and a negative net margin of 0.03%. Cardinal Health’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.31 earnings per share. Analysts predict that Cardinal Health Inc will post 5.08 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were issued a $0.4763 dividend. This represents a $1.91 annualized dividend and a yield of 4.08%. The ex-dividend date of this dividend was Friday, March 29th. Cardinal Health’s dividend payout ratio (DPR) is presently 38.20%.
ILLEGAL ACTIVITY WARNING: This story was first reported by Fairfield Current and is the property of of Fairfield Current. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.fairfieldcurrent.com/news/2019/04/17/cardinal-health-inc-cah-position-lifted-by-trilogy-capital-inc.html.
Cardinal Health Company Profile
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.